Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
NCT00109291 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2012-12-21
Summary
To evaluate the safety profile of single intravenous (IV) dose levels of peginesatide in participants with chronic kidney disease(CKD) not on dialysis.
Conditions
- Anemia
- Chronic Kidney Disease
- Chronic Renal Failure
Interventions
- DRUG
- DRUG
-
peginesatide
Sponsors & Collaborators
-
Affymax
lead INDUSTRY
Principal Investigators
-
Affymax · Affymax, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2006-02-28
- Completion
- 2006-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study of LY3113593 in Participants With Chronic Kidney Disease
NCT02604160 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
NCT00293202 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
NCT01739660 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients
NCT03325621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis
NCT02805244 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome
NCT03019653 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
NCT01971164 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
NCT03612856 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
NCT02044653 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis
NCT00761657 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis
NCT01147666 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease
NCT04059913 ·Status: COMPLETED ·Phase: PHASE4
-
A Renal Impairment Study for PF-04965842
NCT03660241 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis
NCT01737879 ·Status: TERMINATED ·Phase: PHASE4
-
Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients
NCT02754167 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
NCT00285298 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
NCT07165015 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.
NCT00721422 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
NCT02022748 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
NCT00596518 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
NCT02174627 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
NCT01750190 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
NCT04925011 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function
NCT03546205 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
NCT02902679 ·Status: COMPLETED ·Phase: PHASE1